Survey of Ophthalmology
Volume 47, Issue 5 , Pages 431-448 , September 2002

Central Serous Chorioretinopathy and Glucocorticoids

  • Evrydiki A Bouzas, MD

      Affiliations

    • Corresponding Author InformationReprint address: Evrydiki A. Bouzas, Department of Ophthalmology, Henry Dunant Hospital, 107, Mesoghion Avenue, 11526 Athens, Greece
    • Department of Ophthalmology, Henry Dunant Hospital, Athens, Greece
    • ,
  • Panagiotis Karadimas, MD

      Affiliations

    • Department of Ophthalmology, Henry Dunant Hospital, Athens, Greece
    • ,
  • Constantin J Pournaras, MD

      Affiliations

    • Department of Ophthalmology, Geneva University Hospital, Geneva, Switzerland

References 

  1. Abe H, Sonoda H, Sato I. Central serous chorioretinopathy presumably aggravated by steroids. Jpn Rev Clin Ophthalmol. 1983;77:660–664
  2. Abramowicz I: [Retinochoriopathy and adrenocortical crisis in Addisons disease. (Pathological investigations)]. Klin Oczna 40:99–101, 1970
  3. Abu el-AsrarAM . Central serous chorioretinopathy complicating systemic corticosteroid therapy. Eur J Ophthalmol. 1997;7:297–300
  4. Akagi Y, Ogawa K, Hara I. A case of multiple posterior pigment epitheliopathy after renal transplantation from a cadaver. Nippon Ganka Kiyou. 1990;41:1216–1220
  5. Amalric P, Gourinat P, Rebiere P: [Is central serous choroiditis sometimes hereditary?]. Bull Soc Ophtalmol Fr 71:163–8, 1971
  6. Arndt C, Sari A, Ferre M, et al.  Electrophysiological effects of corticosteroids on the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2001;42:472–475
  7. Aronson AJ, Ordonez NG, Diddie KR, Ernest JT. Immune-complex deposition in the eye in systemic lupus erythematosus. Arch Intern Med. 1979;139:1312–1313
  8. Axelrod L. Corticosteroid therapy. In:  Becker KL editors. Principles and Practice of Endocrinology and Metabolism. Philadelphia: J.B. Lippincott Company; 1990;p. 613–623
  9. Balacco-Gabrieli C, Asciano F, Reibaldi A, Santoro M: [Central serous retinopathy. Etiopathogenetic and clinical considerations (authors transl)]. Ophthalmologica 181:251–60, 1980
  10. Barron WM, Mujais SK, Zinaman M, et al.  Plasma catecholamine responses to physiologic stimuli in normal human pregnancy. Am J Obstet Gynecol. 1986;154:80–84
  11. Basti CP. Regulation of cation transport by low doses of glucocorticoids. J Clin Invest. 1987;80:848–856
  12. Bedrossian RH. Letter (Central serous retinopathy and pregnancy). Am J Ophthalmol. 1974;78:152
  13. Benitez del Castillo JM, Castillo A, Fernandez-Cruz A, Garcia-Sanchez J. Persistent choroidopathy in systemic lupus erythematosus. Doc Ophthalmol. 1994;88:175–178
  14. Bennet G. Central serous retinopathy. Br J Ophthalmol. 1955;39:605–618
  15. Benson WE, Shields JA, Annesley WH, Tasman W. Central serous chorioretinopathy with bullous retinal detachment. Ann Ophthalmol. 1980;12:920–924
  16. Bernasconi P, Messmer E, Bernasconi A, Tholen A. Assessment of the sympatho-vagal interaction in central serous chorioretinopathy measured by power spectral analysis of heart rate variability. Graefes Arch Clin Exp Ophthalmol. 1998;236:571–576
  17. Binaghi M. Choriorétinopathie séreuse centrale et idiopathique et épithéliopathie rétinienne diffuse. In:  Soubrane G editors. Affections acquises de l' épithélium pigmentaire rétinien. Bull Soc Ophtalmol Fr: Rapport annuel; 1995;p. 223–241
  18. Bird AC. Pathogenesis of serous detachment of retina and pigment epithelium. In:  Ryan SJ editors. Retina. St Louis: Mosby Inc; 2001;p. 995–1002 ed 3,
  19. Bocci N, Caricato A, Brugnano R. Coriorerinopatia sierosa centrale bilaterale insorta in corso di terapia sistemica con steroidi. Boll di Oculistica. 1991;6:220–226
  20. Boucher MC, el Toukhy EA, Cormier G. Bilateral serous retinal detachments associated with Goodpastures syndrome. Can J Ophthalmol. 1998;33:46–49
  21. Bouzas EA, Mastorakos G. Central serous retinopathy in systemic lupus erythematosus (a manifestation of the disease or of its treatment?). Br J Ophthalmol. 1994;78:420–421
  22. Bouzas EA, Moret P, Pournaras CJ. Central serous chorioretinopathy complicating solar retinopathy treated with glucocorticoids. Graefes Arch Clin Exp Ophthalmol. 1999;237:166–168
  23. Bouzas EA, Scott MH, Mastorakos G, et al.  Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol. 1993;111:1229–1233
  24. Brancato R, Scialdone A, Pece A, et al.  Eight-year follow-up of central serous chorioretinopathy with and without laser treatment. Graefes Arch Clin Exp Ophthalmol. 1987;225:166–168
  25. Browning DJ. Nadolol in the treatment of central serous retinopathy. Am J Ophthalmol. 1993;116:770–771
  26. Burumcek E, Mudun A, Karacorlu S, Arslan MO. Laser photocoagulation for persistent central serous retinopathy (results of long-term follow-up). Ophthalmology. 1997;104:616–622
  27. Calogero AE, Gallucci WT, Chrousos GP, Gold PW. Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro. J Clin Invest. 1988;82:839–846
  28. Carnahan MC, Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol. 2000;11:478–483
  29. Carpenter MT, OBoyle JE, Enzenauer RW, et al.  Choroiditis in systemic lupus erythematosus. Am J Ophthalmol. 1994;117:535–536
  30. Carra G: [Psychosomatic aspects of central serous chorio-retinitis]. Boll Ocul 48:928–33, 1969
  31. Cartier A, Malo JL, Gautrin D, et al.  Glucocorticoid use and risks of ocular hypertension and glaucoma. JAMA. 1997;277:1929–1930
  32. Castro-Correia J, Coutinho MF, Rosas V, Maia J. Long-term follow-up of central serous retinopathy in 150 patients. Doc Ophthalmol. 1992;81:379–386
  33. Chaine G, Haouat M, Menard-Molcard C. Central serous chorioretinopathy and systemic steroid therapy. J Fr Ophthalmol. 2001;24:139–146
  34. Christy NP. Pituitary-adrenal function during corticosteroid therapy. Learning to live with uncertainty. N Engl J Med. 1992;326:266–267
  35. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA. 1992;267:1244–1252
  36. Chumbley LC, Frank RN. Central serous retinopathy and pregnancy. Am J Ophthalmol. 1974;77:158–160
  37. Ciardella AP, Guyer DR, Spitznas M, Yannuzzi LA. Central serous chorioretinopathy. In:  Ryan SJ editors. Retina. St Louis: Mosby Inc; 2001;p. 1153–1181 ed 3,
  38. Cogan DG. Ocular involvement in disseminated intravascular coagulopathy. Arch Ophthalmol. 1975;93:1–8
  39. Cohen D, Gaudric A, Coscas G, et al: [Diffuse retinal epitheliopathy and central serous chorioretinopathy]. J Fr Ophtalmol 6:339–49, 1983
  40. Cohen SM, Kokame GT, Gass JD. Paraproteinemias associated with serous detachments of the retinal pigment epithelium and neurosensory retina. Retina. 1996;16:467–473
  41. Conrad R, Bodeewes I, Schilling G, et al: [Central serous chorioretinopathy and psychological stress]. Ophthalmologe 97:527–31, 2000
  42. Cordes FC. A type of foveomacular retinitis observed in the US Navy. Am J Ophthalmol. 1944;27:803–816
  43. Cousins L, Rigg L, Hollingsworth D, et al.  Qualitative and quantitative assessment of the circadian rhythm of cortisol in pregnancy. Am J Obstet Gynecol. 1983;145:411–416
  44. Cruysberg JR, Deutman AF. Visual disturbances during pregnancy caused by central serous choroidopathy. Br J Ophthalmol. 1982;66:240–241
  45. Cunningham ET, Alfred PR, Irvine AR. Central serous chorioretinopathy in patients with systemic lupus erythematosus. Ophthalmology. 1996;103:2081–2090
  46. Cunningham ET, Bohn MC, Sawchenko PE. Organization of adrenergic inputs to the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Comp Neurol. 1990;292:651–667
  47. Cunningham ET, Sawchenko PE. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol. 1988;274:60–76
  48. Daniele S, Schepens CL, Daniele C, Angeletti G. Fundus abnormalities in Cushings disease (a preliminary report). Ophthalmologica. 1995;209:88–91
  49. De Laey JJ. Central serous chorioretinopathy (to treat or not to treat?). Doc Ophthalmol. 1986;61:367–372
  50. De Laey JJ, Laender R. Unusual aspects of central serous choroidopathy. Bull Soc Belge Ophtalmol. 1978;182:57–73
  51. Desatnik HR, Gutman FA. Bilateral exudative retinal detachment complicating systemic corticosteroid therapy in the presence of renal failure. Am J Ophthalmol. 1996;122:432–434
  52. Deussen A, Sonntag M, Vogel R. L-arginine-derived nitric oxide (a major determinant of uveal blood flow). Exp Eye Res. 1993;57:129–134
  53. Diddie KR, Aronson AJ, Ernest JT. Chorioretinopathy in a case of systemic lupus erythematosus. Trans Am Ophthalmol Soc. 1977;75:122–131
  54. Dinakaran S, Desai SP. Central serous retinopathy associated with Weber-Christian disease. Eur J Ophthalmol. 1999;9:139–141
  55. Doe RP, Dickinson P, Zinneman HH, Seal US. Elevated nonprotein-bound cortisol (NPC) in pregnancy, during estrogen administration and in carcinoma of the prostate. J Clin Endocrinol Metab. 1969;29:757–766
  56. Dufour D, Constantinides G, Capier MJ: [Unusual aspects of simultaneous bilateral central serous choroiditis]. Bull Soc Ophtalmol Fr 72:1129–32, 1972
  57. Eckstein MB, Spalton DJ, Holder G. Visual loss from central serous retinopathy in systemic lupus erythematosus. Br J Ophthalmol. 1993;77:607–609
  58. Ehrlich HP, Tarver H, Hunt TK. Effects of vitamin A and glucocorticoids upon inflammation and collagen synthesis. Ann Surg. 1973;177:222–227
  59. Ernst BB, Lowder CY, Meisler DM, Gutman FA. Posterior segment manifestations of inflammatory bowel disease. Ophthalmology. 1991;98:1272–1280
  60. Fastenberg DM, Ober RR. Central serous choroidopathy in pregnancy. Arch Ophthalmol. 1983;101:1055–1058
  61. Fawzi AA, Cunningham ET. Central serous chorioretinopathy after bone marrow transplantation. Am J Ophthalmol. 2001;131:804–805
  62. Ficker L, Vafidis G, While A, Leaver P. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol. 1988;72:829–834
  63. Flament J, Risse JF, Bronner A: [Bilateral central serous chorio-retinopathy, migratory on 1 side. Discussion of a case]. Bull Soc Ophtalmol Fr 75:455–62, 1975
  64. Folk JC, Thompson HS, Han DP, Brown CK. Visual function abnormalities in central serous retinopathy. Arch Ophthalmol. 1984;102:1299–1302
  65. Fraunfelder FT. Drug-induced ocular side effects. Philadelphia: Williams and Wilkins; 1996; ed 4, pp 284–293
  66. Fraunfelder FT, Meyer SM. Drug-Induced Ocular Side Effects and Drug Interactions. Philadelphia: Lea and Febiger; 1989; ed 3, pp 386–427
  67. Friberg TR, Eller AW. Serous retinal detachment resembling central serous chorioretinopathy following organ transplantation. Graefes Arch Clin Exp Ophthalmol. 1990;228:305–309
  68. Friedman M, Byers SO, Diamant J, Rosenman RH. Plasma catecholamine response of coronary-prone subjects (type A) to a specific challenge. Metabolism. 1975;24:205–210
  69. Garg SP, Dada T, Talwar D, Biswas NR. Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol. 1997;81:962–964
  70. Gass JD. Bullous retinal detachment and multiple retinal pigment epithelial detachments in patients receiving hemodialysis. Graefes Arch Clin Exp Ophthalmol. 1992;230:454–458
  71. Gass JD. Central serous chorioretinopathy and white subretinal exudation during pregnancy. Arch Ophthalmol. 1991;109:677–681
  72. Gass JD. Bullous retinal detachment. An unusual manifestation of idiopathic central serous choroidopathy. Am J Ophthalmol. 1973;75:810–821
  73. Gass JD, Little H. Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology. 1995;102:737–747
  74. Gass JD, Slamovits TL, Fuller DG, et al.  Posterior chorioretinopathy and retinal detachment after organ transplantation. Arch Ophthalmol. 1992;110:1717–1722
  75. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium. II (Idiopathic central serous choroidopathy). Am J Ophthalmol. 1967;63:587–615
  76. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium. I. General concepts and classification. Am J Ophthalmol. 1967;63:573–585
  77. Gass JDM. Stereoscopic Atlas of Macular Diseases. St Louis: CV Mosby Co; 1997; ed 4, pp 52–70
  78. Gass JDM. Stereoscopic Atlas of Macular Diseases (Diagnosis and Treatment). St Louis: CV Mosby Co; 1977; ed 2, pp 28–41
  79. Gass JDM. Stereoscopic atlas of macular diseases. St Louis: CV Mosby Co; 1970;
  80. Gelber GS, Schatz H. Loss of vision due to central serous chorioretinopathy following psychological stress. Am J Psychiatry. 1987;144:46–50
  81. Gifford SR, Marquardt G. Central angiospastic retinopathy. Arch Ophthalmol. 1939;21:211–228
  82. Gilbert CM, Owens SL, Smith PD, Fine SL. Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol. 1984;68:815–820
  83. Gill GN. The adrenal gland. In:  West JB editors. Best and Taylor's physiological basis of medical practice. Baltimore: Williams and Wilkins; 1990;p. 820–830 ed 12,
  84. Godel V, Blumenthal M, Regenbogen L. Retrobulbar neuritis and central serous chorioretinopathy. J Pediatr Ophthalmol. 1977;14:296–298
  85. Gravanis A, Margioris AN, Pharmacology of glucocorticoids . an overview. In:  Margioris AN,  Chroussos GP editor. Adrenal Disorders. Totowa, NJ: Humana Press; 2001;p. 59–70
  86. Guyer DR, Yannuzzi LA, Slakter JS, et al.  Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol. 1994;112:1057–1062
  87. Hadcock JR, Malbon CC. Regulation of beta-adrenergic receptors by permissive hormones (glucocorticoids increase steady-state levels of receptor mRNA). Proc Natl Acad Sci USA. 1988;85:8415–8419
  88. Haik GM, Perez LF, Murtagh JJ. Central serous retinopathy. Consecutive development in daughter and mother. Am J Ophthalmol. 1968;65:612–615
  89. Haimovici R, Gragoudas ES, Duker JS, et al.  Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology. 1997;104:1653–1660
  90. Hannouche D, Korobelnik JF, Cochereau I, et al.  Systemic lupus erythematosus with choroidopathy and serous retinal detachment. Int Ophthalmol. 1995;19:125–127
  91. Harada T, Harada K. Six cases of central serous choroidopathy induced by systemic corticosteroid therapy. Doc Ophthalmol. 1985;60:37–44
  92. Hardy P, Abran D, Li DY, et al.  Free radicals in retinal and choroidal blood flow autoregulation in the piglet (interaction with prostaglandins). Invest Ophthalmol Vis Sci. 1994;35:580–591
  93. Hardy P, Nuyt AM, Abran D, et al.  Nitric oxide in retinal and choroidal blood flow autoregulation in newborn pigs (interactions with prostaglandins). Pediatr Res. 1996;39:487–493
  94. Hardy P, Peri KG, Lahaie I, et al.  Increased nitric oxide synthesis and action preclude choroidal vasoconstriction to hyperoxia in newborn pigs. Circ Res. 1996;79:504–511
  95. Harrington DO. Psychosomatic interrelationships in ophthalmology. Am J Ophthalmol. 1948;31:1241–1251
  96. Harris MA, Schwartz B. Steroid potentiation of beta-adrenergic-sensitive adenylate cyclase in rabbit ciliary processes. Invest Ophthalmol Vis Sci. 1987;28:1024–1027
  97. Harrison TS, Chawla RC, Wojtalik RS. Steroidal influences on catecholamines. N Engl J Med. 1968;279:136–143
  98. Hartman DM. La retinopathie centrale angiospastique. Bull Soc Ophthalmol Fr. 1952;52:110–120
  99. Hayashi K, Hasegawa Y, Tokoro T. Indocyanine green angiography of central serous chorioretinopathy. Int Ophthalmol. 1986;9:37–41
  100. Hirch Pescovitz O, Cutler GB, Loriaux DL. Synthesis and secretion of corticosteroids. In:  Becker KL editors. Principles and Practice of Endocrinology and Metabolism. Philadelphia: J.B. Lippincott Company; 1990;p. 579–591
  101. Hiwatashi E, Miyashita K. Multifocal posterior pigment epitheliopathy developed in a case of SLE retinopathy. Ganka Rinsho Iho. 1993;87:1030–1033
  102. Hobbs HE. Macular degeneration treated with cortisone. Proc Roy Soc Med. 1953;46:213–218
  103. Hooymans JM. Fibrotic scar formation in central serous chorioretinopathy developed during systemic treatment with corticosteroids. Graefes Arch Clin Exp Ophthalmol. 1998;236:876–879
  104. Horniker E. Su di unaforma di retinite centrale di origine vasoneurotica. Ann Oftalmol. 1927;55:578–600
  105. Ie D, Yannuzzi LA, Spaide RF, et al.  Subretinal exudative deposits in central serous chorioretinopathy. Br J Ophthalmol. 1993;77:349–353
  106. Iida T, Spaide RF, Negrao SG, et al.  Central serous chorioretinopathy after epidural corticosteroid injection. Am J Ophthalmol. 2001;132:423–425
  107. Ikeda N, Numata K, Takeda N. A case of pigment epitheliopathy in a patient with polymyositis induced by corticosteroid therapy. Nippon Ganka Kiyou. 1993;44:1546–1551
  108. Inoue T, Miyamoto F. A case of central serous chorioretinopathy during corticosteroid treatment for Vogt-Koyanagi Harada syndrome. Ganka Rinsho Iho. 1985;79:1849–1853
  109. Jabs DA, Hanneken AM, Schachat AP, Fine SL. Choroidopathy in systemic lupus erythematosus. Arch Ophthalmol. 1988;106:230–234
  110. Jain IS, Singh K. Maculopathy a corticosteroid side-effect. J All India Ophthalmol Soc. 1966;14:250–252
  111. Jalkh AE, Jabbour N, Avila MP, et al.  Retinal pigment epithelium decompensation. I. Clinical features and natural course. Ophthalmology. 1984;91:1544–1548
  112. Jampol LM, Lahov M, Albert DM, Craft J. Ocular clinical findings and basement membrane changes in Goodpastures syndrome. Am J Ophthalmol. 1975;79:452–463
  113. Jellie HG, Gonder JR, Canny CL, et al.  Ocular involvement in thrombotic thrombocytopenic purpura (the angiographic and histopathological features). Can J Ophthalmol. 1984;19:279–283
  114. Kaneko E, Nawano M, Honda N, et al.  Ulcerative colitis complicated by idiopathic central serous chorioretinopathy with bullous retinal detachment. Dig Dis Sci. 1985;30:896–900
  115. Kao LY. Bilateral serous retinal detachment resembling central serous chorioretinopathy following epidural steroid injection. Retina. 1998;18:479–481
  116. Kapetanios AD, Donati G, Bouzas E, et al: [Serous central chorioretinopathy and endogenous hypercortisolemia]. Klin Monatsbl Augenheilkd 212:343–4, 1998
  117. Kato Y, Kato M, Kogure M. Two cases of central serous chorioretinopathy induced by corticosteroid treatment. Ganka Rinsho Iho. 1982;76:1418–1421
  118. Katsimpris J, Donati G, Kapetanios A, et al: [Value of indocyanine green angiography in detection of central serous chorioretinopathy]. Klin Monatsbl Augenheilkd 218:335–7, 2001
  119. Kayazawa F. Central serous choroidopathy with exudative retinal detachment. Ann Ophthalmol. 1988;106:230–234
  120. Khairallah M, Nouira F, Gharsallah R, Chachia N: [Central serous chorioretinopathy in a pregnant woman]. J Fr Ophtalmol 19:216–21, 1996
  121. Khng CG, Yap EY, Au-Eong KG, et al.  Central serous retinopathy complicating systemic lupus erythematosus (a case series). Clin Experiment Ophthalmol. 2000;28:309–313
  122. Kinoshita C, Yamashita T, Yoshimura T. A case of chronic nephritis with multifocal posterior pigment epitheliopathy. Nippon Ganka Kiyo. 1988;39:769–773
  123. Kinyoun JL, Kalina RE. Visual loss from choroidal ischemia. Am J Ophthalmol. 1986;101:650–656
  124. Kitigawa K, Hayasaka S. Central serous chorioretinopathy in a patient with ulcerative colitis. Ann Ophthalmol. 1996;28:118–120
  125. Klein ML, Van Buskirk EM, Friedman E, et al.  Experience with nontreatment of central serous choroidopathy. Arch Ophthalmol. 1974;91:247–250
  126. Knox DL, Schachat AP, Mustonen E. Primary, secondary and coincidental ocular complications of Crohns disease. Ophthalmology. 1984;91:163–173
  127. Kvetnansky R, Pacak K, Fukuhara K, et al.  Sympathoadrenal system in stress. Interaction with the hypothalamic- pituitary-adrenocortical system. Ann NY Acad Sci. 1995;771:131–158
  128. Laatikainen L. Diffuse chronic retinal pigment epitheliopathy and exudative retinal detachment. Acta Ophthalmol (Copenh). 1994;72:533–536
  129. Lambert SR, High KA, Cotlier E, Benz EJ. Serous retinal detachments in thrombotic thrombocytopenic purpura. Arch Ophthalmol. 1985;103:1172–1174
  130. Leuenberger A, Gasche A: [Light coagulation for central serous retinopathy]. Ophthalmologica 165:366–72, 1972
  131. Levine R, Brucker AJ, Robinson F. Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography. Ophthalmology. 1989;96:854–859
  132. Lin E, Arrigg PG, Kim RY. Familial central serous choroidopathy. Graefes Arch Clin Exp Ophthalmol. 2000;238:930–931
  133. Lin JM, Tsai YY. Retinal pigment epithelial detachment in the fellow eye of a patient with unilateral central serous chorioretinopathy treated with steroid. Retina. 2001;21:377–379
  134. Lipowski ZJ, Kiriakos RZ. Psychosomatic aspects of central serous retinopathy. A review and case report. Psychosomatics. 1971;12:398–401
  135. Lowder CY, Gutman FA, Zegarra H, et al.  Macular and paramacular detachment of the neurosensory retina associated with systemic diseases. Trans Am Ophthalmol Soc. 1981;79:347–370
  136. Luger A, Deuster PA, Kyle SB, et al.  Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. N Engl J Med. 1987;316:1309–1315
  137. Lyons DE. Conservative management of central serous retinopathy. Trans Ophthalmol Soc UK. 1977;97:214–216
  138. Mandelcorn M, Mednick E. Eccentric serous choroidopathy (a case report). Can J Ophthalmol. 1979;14:102–105
  139. Mann RM, Riva CE, Stone RA, et al.  Nitric oxide and choroidal blood flow regulation. Invest Ophthalmol Vis Sci. 1995;36:925–930
  140. Marmor MF. New hypotheses on the pathogenesis and treatment of serous retinal detachment. Graefes Arch Clin Exp Ophthalmol. 1988;226:548–552
  141. Marmor MF, Yao XY. Conditions necessary for the formation of serous detachment. Experimental evidence from the cat. Arch Ophthalmol. 1994;112:830–838
  142. Matsukura S, Miyashita K, Hiraga S. Four cases of central serous chorioretinopathy following renal transplantation. Rinsho Ganka. 1993;47:1719–1724
  143. Matsumoto Y, Ishibashi Y, Kono K. Bullous retinal detachment associated with malignant melanoma and massive steroid therapy. Rinsho Ganka. 1983;37:1377–1383
  144. Matsunaga H, Nishimura T, Uyama N. Recent cases of multifocal posterior pigment epitheliopathy. Rinsho Ganka. 1992;46:729–733
  145. Matsuo T, Nakayama T, Koyama T, Matsuo N. Multifocal pigment epithelial damages with serous retinal detachment in systemic lupus erythematosus. Ophthalmologica. 1987;195:97–102
  146. Mazzuca DE, Benson WE. Central serous retinopathy (variants). Surv Ophthalmol. 1986;31:170–174
  147. McLean JM, Gordon DM, Koteen H. Clinical experiences with ACTH and cortisone in ocular diseases. Trans Am Acad Ophthalmol Otolaryngol. 1951;55:565–575
  148. Meyers FH, Jawetz E, Goldfien A. Review of Medical Pharmacology. Los Altos: Lange Medical Publications; 1980; ed 7, pp 352–68
  149. Miki T, Sunada I, Higaki T: [Studies on chorioretinitis induced in rabbits by stress (repeated administration of epinephrine)]. Nippon Ganka Gakkai Zasshi 76:1037–45, 1972
  150. Miura K, Ueno M, Miura Y. Central serous chorioretinopathy induced by systemic corticosteroid therapy. Nippon Ganka Kiyou. 1989;40:59–64
  151. Miura M, Murakami K, Yamada Y. A case of bullous retinal detachment associated with ulcerative colitis. Nippon Ganka Kiyou. 1990;41:360–364
  152. Nadel AJ, Turan MI, Coles RS. Central serous retinopathy. A generalized disease of the pigment epithelium. Mod Probl Ophthalmol. 1979;20:76–88
  153. Nagayoshi K: [Experimental study of choroidoretinopathy by intravenous injection of adrenaline]. Nippon Ganka Gakkai Zasshi 75:1720–7, 1971
  154. Nanjiani M. Long-term follow-up of central serous retinopathy. Trans Ophthalmol Soc UK. 1977;97:656–661
  155. Natrajan PG, McGarrigle HH, Lawrence DM, Lachelin GC. Plasma noradrenaline and adrenaline levels in normal pregnancy and in pregnancy-induced hypertension. Br J Obstet Gynaecol. 1982;89:1041–1045
  156. Negi A, Marmor MF. Experimental serous retinal detachment and focal pigment epithelial damage. Arch Ophthalmol. 1984;102:445–449
  157. Nolten WE, Rueckert PA. Elevated free cortisol index in pregnancy (possible regulatory mechanisms). Am J Obstet Gynecol. 1981;139:492–498
  158. Ogawa T, Ishikawa K, Inokuchi T. A case of multifocal pigment epitheliopathy with nephrotic syndrome. Nippon Ganka Kiyou. 1989;40:1744–1751
  159. Oikarinen AI, Uitto J, Oikarinen J. Glucocorticoid action on connective tissue (from molecular mechanisms to clinical practice). Med Biol. 1986;64:221–230
  160. Oosterhuis JA. Familial central serous retinopathy. Graefes Arch Clin Exp Ophthalmol. 1996;234:337–341
  161. Orth DN, Kovacs WJ, DeBold CR. The adrenal cortex. In:  Wilson JD,  Foster DW editor. Williams Textbook of Endocrinology. Philadelphia: WB Saunders Co; 1992;p. 489–619 ed 8,
  162. Ozsoylu S, Strauss H, Diamond LK. Effects of corticosteroid on coagulation of the blood. Nature. 1962;195:1214–1215
  163. Park DW, Schatz H, Gaffney MM, et al.  Central serous chorioretinopathy in two families. Eur J Ophthalmol. 1998;8:42–47
  164. Percival SP. Ocular findings in thrombotic thrombocytopenic purpura (Moschcowitzs disease). Br J Ophthalmol. 1970;54:73–78
  165. Peyman GA, Bok D. Peroxidase diffusion in the normal and laser-coagulated primate retina. Invest Ophthalmol. 1972;11:35–45
  166. Piccolino FC. Central serous chorioretinopathy (some considerations on the pathogenesis). Ophthalmologica. 1981;182:204–210
  167. Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina. 1994;14:231–242
  168. Piccolino FC, Borgia L, Zinicola E, Zingirian M. Indocyanine green angiographic findings in central serous chorioretinopathy. Eye. 1995;9:324–332
  169. Polak BC, Baarsma GS, Snyers B. Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment. Br J Ophthalmol. 1995;79:922–925
  170. Pomerleau OF, Pomerleau CS. Cortisol response to a psychological stressor and/or nicotine. Pharmacol Biochem Behav. 1990;36:211–213
  171. Pratt WBM, Aronow L. The effect of glucocorticoids on protein and nucleic acid synthesis in mouse fibroblasts. J Biol Chem. 1966;241:5244–5250
  172. Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol. 1996;121:26–34
  173. Purnell JE, Leopold IH. Cortisone in ocular disease (further studies). Am J Ophthalmol. 1952;35:663–670
  174. Quillen DA, Gass DM, Brod RD, et al.  Central serous chorioretinopathy in women. Ophthalmology. 1996;103:72–79
  175. Sahu DK, Namperumalsamy P, Hilton GF, de Sousa NF. Bullous variant of idiopathic central serous chorioretinopathy. Br J Ophthalmol. 2000;84:485–492
  176. Sakaue M, Hoffman BB. Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J Clin Invest. 1991;88:385–389
  177. Sandle GI, McGlone F. Acute effects of dexamethasone on cation transport in colonic epithelium. Gut. 1987;28:701–706
  178. Saraux H, Pelosse B, Bouzas E: [Retrospective study of patients treated with the laser for central serous choroidopathies]. Bull Soc Belge Ophtalmol 220:1–4, 1986
  179. Scarpace PJ, Baresi LA, Morley JE. Glucocorticoids modulate beta-adrenoceptor subtypes and adenylate cyclase in brown fat. Am J Physiol. 1988;255:E153–E158
  180. Schatz H, Madeira D, Johnson RN, McDonald HR. Central serous chorioretinopathy occurring in patients 60 years of age and older. Ophthalmology. 1992;99:63–67
  181. Schatz H, McDonald HR, Johnson RN, et al.  Subretinal fibrosis in central serous chorioretinopathy. Ophthalmology. 1995;102:1077–1088
  182. Scheider A, Nasemann JE, Lund OE. Fluorescein and indocyanine green angiographies of central serous choroidopathy by scanning laser ophthalmoscopy. Am J Ophthalmol. 1993;115:50–56
  183. Schreiber JB, Lakhanpal V, Nasrallah SM. Crohns disease complicated by idiopathic central serous chorioretinopathy with bullous retinal detachment. Dig Dis Sci. 1989;34:118–122
  184. Sedan J. Ocular complications due to cortisone and the attempts made to neutralize them. Ann Ocul (Paris). 1966;199:601–614
  185. Sharma S. Bilateral serous retinal detachments associated with Goodpastures syndrome. Can J Ophthalmol. 1998;33:226–227
  186. Sharma T, Badrinath SS, Gopal L, et al.  Subretinal fibrosis and nonrhegmatogenous retinal detachment associated with multifocal central serous chorioretinopathy. Retina. 1998;18:23–29
  187. Shimaya M, Yamazaki Y, Imai J. A case of therapy-resistant scleritis associated with chronic rheumatism. Jpn Rev Clin Ophthalmol. 1978;78:213–216
  188. Smith PR, Benos DJ. Epithelial Na+ channels. Annu Rev Physiol. 1991;53:509–530
  189. Smith TJ. Dexamethasone regulation of glycosaminoglycan synthesis in cultured human skin fibroplasts. J Clin Invest. 1983;74:2157–2163
  190. Snyers B, Kestens C: [Central serous choroiditis following renal transplantation]. Bull Soc Belge Ophtalmol 239:87–101, 1990
  191. Spaide RF, Hall L, Haas A. Indocyanine green videoangiography of central serous chorioretinopathy in older adults. Retina. 1996;16:78–80
  192. Spitznas M. Pathogenesis of central serous retinopathy (a new working hypothesis). Graefes Arch Clin Exp Ophthalmol. 1986;224:321–324
  193. Spitznas M. Central serous retinopathy. In:  Ryan SJ,  Schachat AP,  Murphy RP,  Patz A editor. Retina. St Louis: CV Mosby Co; 1989;p. 217–227
  194. Spraul CW, Lang GE, Lang GK. Retinal pigment epithelial changes associated with systemic corticosteroid treatment (report of cases and review of the literature). Ophthalmologica. 1998;212:142–148
  195. Spraul CW, Lang GE, Lang GK: [Central serous chorioretinopathy in systemic therapy with corticosteroids]. Ophthalmologe 94:392–6, 1997
  196. Suehiro T, Hosoya T. A case of central chorioretinopathy during systemic corticosteroid therapy. Nippon Ganka Kiyou. 1994;45:879–882
  197. Sunness JS. The pregnant womans eye. Surv Ophthalmol. 1988;32:219–238 -
  198. Sunness JS, Haller JA, Fine SL. Central serous chorioretinopathy and pregnancy. Arch Ophthalmol. 1993;111:360–364
  199. Suzuki Y, Kogure M, Kato M. A case of multifocal posterior pigment epitheliopathy following renal transpantation. Ganka Rinso Iho. 1986;80:212–214
  200. Szabo C, Thiemermann C, Vane JR. Inhibition of the production of nitric oxide and vasodilator prostaglandins attenuates the cardiovascular response to bacterial endotoxin in adrenalectomized rats. Proc R Soc Lond B Biol Sci. 1993;253:233–238
  201. Tamiya R, Takahashi K, Matsubara T. Multifocal posterior pigment epitheliopathy in a case of lupus nephritis. Rinsho Ganka. 1994;48:1757–1763
  202. Theodossiadis G, Tongos D. Treatment of central serous retinopathy. A comparative study with and without light coagulation. Ophthalmologica. 1974;169:416–431
  203. Thoelen AM, Bernasconi PP, Schmid C, Messmer EP. Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex. Retina. 2000;20:98–99
  204. Tittl MK, Spaide RF, Wong D, et al.  Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol. 1999;128:63–68
  205. Troiano P, Buccianti G. Bilateral symmetric retinal detachment and multiple retinal pigment epithelial detachments during haemodialysis. Nephrol Dial Transplant. 1998;13:2135–2137
  206. Tsukahara I, Morii F. A peculiar type of secondary detachment of the retina. With special reference to central serous choroidopathy and peripheral uveitis. J Clin Ophthalmol (Tokyo). 1974;27:1003–1008
  207. Tsukahara I, Uyama M. Central serous choroidopathy with bullous retinal detachment. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1978;206:169–178
  208. Urayama A, Hatakeyama T, Macida A, Abe N. Two cases of central chorioretinitis followed by retinal detachment. Jap J Clin Ophthalmol. 1971;25:731–735
  209. Urban RC, Cotlier E. Corticosteroid-induced cataracts. Surv Ophthalmol. 1986;31:102–110
  210. Uyama M, Tsukahara I, Asayama K. Multifocal posterior pigment epitheliopathy (clinical features and treatment with phototcoagulation). Jap J Clin Ophthalmol. 1977;31:359–372
  211. von Graefe A. Ueber centrale recidivierende retinitis. Graefes Arch Clin Exp Ophthalmol. 1866;12:211–215
  212. von Winning CH, Oosterhuis JA, Renger-van Dijk AH, et al.  Diffuse retinal pigment epitheliopathy. Ophthalmologica. 1982;185:7–14
  213. Wakakura M. Serous retinal detachment in thrombotic thrombocytopenic purpura and corticosteroid therapy. Arch Ophthalmol. 1986;104:177–178
  214. Wakakura M, Ishikawa S. Central serous chorioretinopathy complicating systemic corticosteroid treatment. Br J Ophthalmol. 1984;68:329–331
  215. Wakakura M, Ishikawa S. An evaluation of corticosteroid treatment for central serous retinopathy. Rinsho Ganka. 1980;34:123–129
  216. Wakakura M, Song E, Ishikawa S. Corticosteroid-induced central serous chorioretinopathy. Jpn J Ophthalmol. 1997;41:180–185
  217. Wakakura M, Suzuki H. Urinary excretion of catecholamines in central serous chorioretinopathy. Jpn J Clin Ophthalmol. 1979;33:1237–1240
  218. Wakakura M, Yoshida H, Tani I. Effect of systemic corticosteroid on the outer bloodretinal barrier (report of three cases). Rinsho Ganka. 1981;35:1037–1041
  219. Weenink AC, Borsje RA, Oosterhuis JA. Familial chronic central serous chorioretinopathy. Ophthalmologica. 2001;215:183–187
  220. Wessing A. Changing concept of central serous retinopathy and its treatment. Trans Am Acad Ophthalmol Otolaryngol. 1973;77:OP275–OP280
  221. Williams RB. Physiological mechanisms underlying disease. In:  Gentry WD,  Williams RB editor. Physiological Aspects of Myocardial Infraction and Coronary Care. St Louis: CV Mosby Co; 1975;p. 131–146
  222. Williams RB, Lane JD, Kuhn CM, et al.  Type A behavior and elevated physiological and neuroendocrine responses to cognitive tasks. Science. 1982;218:483–485
  223. Williamson J, Dalakos TG. Posterior subcapsular cataracts and macular lesions after long-term corticotrophin therapy. Br J Ophthalmol. 1967;51:839–842
  224. Williamson J, Nuki G. Macular lesions during systemic therapy with depot tetracosactrin. Br J Ophthalmol. 1970;54:405–409
  225. Worrall NK, Misko TP, Sullivan PM, et al.  Corticosteroids inhibit expression of inducible nitric oxide synthase during acute cardiac allograft rejection. Transplantation. 1996;61:324–328
  226. Wyszynski RE, Frank KE, Grossniklaus HE. Bilateral retinal detachments in thrombotic thrombocytopenic purpura. Graefes Arch Clin Exp Ophthalmol. 1988;226:501–504
  227. Yamazaki A, Tamai A, Hamamoto J. A case of Fishers' syndrome associated with central serous chorioretinopathy. Shinkei Ganka. 1995;12:199–207
  228. Yannuzzi LA. Type-A behavior and central serous chorioretinopathy. Retina. 1987;7:111–131
  229. Yannuzzi LA, Shakin JL, Fisher YL, Altomonte MA. Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology. 1984;91:1554–1572
  230. Yao XY, Marmor MF. Induction of serous retinal detachment in rabbit eyes by pigment epithelial and choriocapillary injury. Arch Ophthalmol. 1992;110:541–546
  231. Yard AC, Kadowitz PJ. Studies on the mechanism of hydrocortisone potentiation of vasoconstrictor responses to epinephrine in the anesthetized animal. Eur J Pharmacol. 1972;20:1–9
  232. Yasuzumi T, Miki T, Sugimoto K: [Electronmicroscopic studies of epinephrine choroiditis in rabbits. I. Pigment epithelium and Bruchs membrane in the healed stage (authors transl)]. Nippon Ganka Gakkai Zasshi 78:588–98, 1974
  233. Yoshioka H, Katsume Y. Experimental central serous chorioretinopathy. III (ultrastructural findings). Jpn J Ophthalmol. 1982;26:397–409
  234. Yoshioka H, Katsume Y, Akune H. Experimental central serous chorioretinopathy in monkey eyes (fluorescein angiographic findings). Ophthalmologica. 1982;185:168–178
  235. Yoshioka H, Sugita T, Nagayoshi K: [Fluorescein angiographic findings in experimental retinopathy produced by intravenous adrenaline injection. Preliminary report]. Nippon Ganka Kiyo 21:648–52, 1970
  236. Zamir E. Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and a hypothesis. Graefes Arch Clin Exp Ophthalmol. 1997;235:339–344
  237. Zeligs MA. Central angiospastic retinopathy (a psychosomatic study of the occurrence in military personnel). Psychosom Med. 1947;9:110–117
  238. Zweng HC, Little H. Diffuse retinal pigment epitheliopathy. In:  Zweng HC,  Little HL editor. Argon Laser Photocoagulation. St Louis: Mosby; 1977;p. 117–126

PII: S0039-6257(02)00338-7

Survey of Ophthalmology
Volume 47, Issue 5 , Pages 431-448 , September 2002

Article Tools

* Image Usage & Resolution